MedPath
NMPA Approval

Ibuprofen Suspension

国药准字H20233008

January 3, 2023

Drug Information

布洛芬混悬液

口服混悬剂

100ml:2g

化学药品

January 3, 2023

Company Information

Applicant Company

山东省潍坊市高密市高密高新技术产业开发区高新二路(西)6号

Manufacturing Company

山东省滕州市益康大道3288号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

布洛芬混悬液 - NMPA 批准文号 | MedPath